Fondazione Policlinico Universitario Agostino Gemelli IRCCS: Pancreatic Neoplasms trials
The registry lists 11 Pancreatic Neoplasms studies with Fondazione Policlinico Universitario Agostino Gemelli IRCCS as lead sponsor. 7 are open to participants now and 0 have results posted.
Phase 2 1Phase 3 1No phase 9(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Exocrine-Endocrine Pancreatic Crosstalk: Precision Pathways to Reframe Diabetes PathophysiologyNot yet recruitingNCT07670871
- Clinical, Oncologic, and Metabolic Effects of Pancreatic Mass Loss After Pancreatectomy in Non-Diabetic PatientsRecruitingNCT07608055
- Clinical, Oncological and Metabolic Effects of Pancreatic Mass Loss After Partial, Near-total and Total Pancreatectomy in Patients With Preoperative Diabetes MellitusNot yet recruitingNCT07607912
- Microplastics in Pancreas: Oncologic and Metabolic ImpactNot yet recruitingNCT07486128
- Identification of New Theranostic Biomarkers of Pancreatic Tumor ProgressionRecruitingNCT06574373
- Use of Ctdna in Patients With Gastrointestinal Tract TumorsRecruitingNCT06202131
- Combined Nabpaclitaxel Pressurized IntraPeritoneal Aerosol Chemotherapy With Systemic Nabpaclitaxel-Gemcitabine Chemotherapy for Pancreatic Cancer Peritoneal MetastasesRecruitingNCT05371223Phase 2
- SENECA: First Line metaStatic pancrEatic caNcer Primary and Distant (if Oligometastatic) lEsion direCted rAdiotherapyActive, not recruitingNCT06946420Phase 3
- IMPact of AerobiC Exercise in Addition to Nutritional Treatment on Quality of Life After PancreatectomyActive, not recruitingNCT06858631Not applicable
- The Future Management of Patients With Neoplasms of the Gastro-intestinal TractActive, not recruitingNCT06728358Not applicable
- Covid-19 Pandemic and Pancreatic Surgery in ItalyCompletedNCT04380766